"Centre for Cancer Biomedicine" selected as new CoE-centre
These were selected in hard competition between the 26 outstanding research groups that had reached the final selection round. The eight new CoE's will altogehter receive 800 million NOK during the next 10 years.

Harald Stenmark is the CoE director for the "Centre for Cancer Biomedicine", and vice director is Ragnhild A. Lothe. The other main participants are Erlend B. Smeland, Håvard E. Danielsen, Kirsten Sandvig, Sjur Olsnes, Antoni Wiedlocha and Knut Liestøl.
Photo:
From the surprise visit to Stenmark's office
(From left): Harald Stenmark, Øystein Djupedal and Arvid Hallén.
(click to enlarge image)